Clinical Trial Search

Primary: Development of VAP (Clinical Pulmonary Infection Score) — 4.13; 4.45 units on a scale — p=0.1763

Primary: Total Number of Deaths in the Pre vs Post-intervention Time Periods Among Study Participants Per 1000 Mechanically Ventilated Patient Days — 72; 73 Deaths per 1000…

Primary: Change in Antibiotic Usage or Exposure — 11.87; 7.76 days — p=0.26

Primary: Quality of Life - 36-item Short-Form General Health Survey — 40.5; 40.0; 48.9; 45.9 score on a scale — p=0.78

Primary: Percentage of Patients With Tracheal Bacterial Colonization — 8; 7; 9 percentage of tracheal colonization

Primary: Number of Patients That Experience Pulmonary Complications After Admission From the Emergency Department — 171; 38 participants

Primary: Percentage of Participants With Nosocomial Pneumonia Caused by Pseudomonas Aeruginosa — 18.1; 12.5; 22.4 Percentage of participants — p=0.491

Primary: To Further Characterize ED Mechanical Ventilation — 500 mL

Primary: Compare Ventilator Associated Pneumonia Rates in Patients Receiving Early Enteral Feeding Without Residual Gastric Volume (RGV) Monitoring and in Patients With RGV…

Primary: Length of Hospital Stay — 3.5; 3.6; 4.5 days

Primary: Severity of Pulmonary Complications in the Post-operative Period — 15; 26 percentage of participants — p=0.016

Primary: Microaspiration as Measured by Tracheal Amylase — 13,086; 15,298 U/L — p=0.432

Primary: Percentage of Participants With All Cause Mortality in the Intent-to-Treat (ITT) Population - Day 28 — 24.0; 25.3 Percentage of Participants

Primary: Mortality — 10; 14 participants — p=0.03

Primary: Number of Participants Who Survived and Died — 1; 31; 14; 19 Participants

Primary: Incidence of Ventilator-Associated Pneumonia (VAP) — 16; 27 Participants

Primary: Number of Participants Surviving Through LFU Visit — 191; 196; 64; 57 Participants — p=0.4263

Primary: Ventilator-free Days (VFDs) to Day 28 After Enrollment — 23; 22; 24 Ventilator-free days to day 28

Primary: Respiratory System Driving Pressure Measure by Servo Ventilator (DPrs-servo) — 12.3 centimeters of water

Primary: Colonization of the Oral Cavity by Respiratory Pathogens (on Teeth/Denture/Buccal Mucosa) as Determined by Quantitative Cultures Expressed as Colony Forming Units (Cfu)…

Primary: Functional Assessment: Handgrip — 3.6; 1.3 kg

Primary: Oxygen Desaturation Index 4% (ODI4%) — 3.16; 7.61 events per hour — p=0.0134

Primary: Pathogens of Healthcare Associated Pneumonia, Measured by the Number of Participants — 15; 51; 195; 269 Participants

Primary: Percent Reduction in Oxygen Requirement From Baseline — 5.4; 16.5 percentage FiO2

Primary: Clinical Response — 2.9; 2.9 score on a scale — p=<0.01

Primary: Percentage of Time Spent With Arterial Oxygen Saturation < 75% — 5; 4.4 % of time — p=0.44

Primary: to Evaluate the Efficacy of CPAP (Group A) in Comparison With Oxygen Therapy With Venturi Mask (Group B, Standard Therapy) in Terms of Achievement of Criteria for…

Primary: Reintubation — 57; 52 Participants

Primary: Change From Baseline in Clinical Pulmonary Infection Score (CPIS) For Each Patient, Value Obtained From a Daily Assessment Over the 10 Day Study Period Was Compared to…

Primary: Venilator Associated Events (VAE) — 44; 40; 4; 2 Participants